Article Versions Notes

Kántor I, Dreavă D, Todea A, Péter F, May Z, Biró E, Babos G, Feczkó T. Co-Entrapment of Sorafenib and Cisplatin Drugs and iRGD Tumour Homing Peptide by Poly[ε-caprolactone-co-(12-hydroxystearate)] Copolymer. Biomedicines. 2022; 10(1):43. https://doi.org/10.3390/biomedicines10010043

Kántor, Izolda, Diana Dreavă, Anamaria Todea, Francisc Péter, Zoltán May, Emese Biró, György Babos, and Tivadar Feczkó. 2022. "Co-Entrapment of Sorafenib and Cisplatin Drugs and iRGD Tumour Homing Peptide by Poly[ε-caprolactone-co-(12-hydroxystearate)] Copolymer" Biomedicines 10, no. 1: 43. https://doi.org/10.3390/biomedicines10010043

Kántor, I., Dreavă, D., Todea, A., Péter, F., May, Z., Biró, E., Babos, G., & Feczkó, T. (2022). Co-Entrapment of Sorafenib and Cisplatin Drugs and iRGD Tumour Homing Peptide by Poly[ε-caprolactone-co-(12-hydroxystearate)] Copolymer. Biomedicines, 10(1), 43. https://doi.org/10.3390/biomedicines10010043